RNA | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug monographs and related information

Approved pharmaceutical products by global regulatory authorities

Explore a comprehensive list of organizations, including their profiles and details

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 452 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "RNA"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Quantifying Micro RNA Levels of Colon

Conditions: Colorectal Carcinoma (CRC) Patients

First Posted Date: 2012-10-24

Last Posted Date: 2012-10-24

Lead Sponsor: Meir Medical Center

Target Recruit Count: 100

Registration Number: NCT01712958

Locations: 🇮🇱
Meir Medical Center, Kfar-Saba, Israel

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Phase 3

Completed

Conditions: Human Immunodeficiency Virus-type 1 Infection

Interventions: Drug: Rilpivirine
Drug: Efavirenz
Drug: Tenofovir disoproxil fumarate
Drug: Emtricitabine

First Posted Date: 2012-10-17

Last Posted Date: 2021-02-11

Lead Sponsor: Janssen-Cilag International NV

Target Recruit Count: 426

Registration Number: NCT01709084

RBL001/RBL002 Phase I Clinical Trial

Phase 1

Completed

Conditions: Melanoma

Interventions: Biological: RBL001/RBL002

First Posted Date: 2012-09-12

Last Posted Date: 2020-01-18

Lead Sponsor: BioNTech RNA Pharmaceuticals GmbH

Target Recruit Count: 29

Registration Number: NCT01684241

Locations: 🇦🇹
Medizinische Universität Wien, Abteilung für Dermatologie, Vienna, Austria
🇩🇪
Universtitätsmedizin der Johannes-Gutenberg Universtität, Mainz, Germany
🇩🇪
Universitätsklinik Mannheim, Mannheim, Germany

and more 1 locations

36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8

Phase 4

Conditions: Hepatitis C Infection

Interventions: Drug: Pegintron + Riba

First Posted Date: 2012-09-12

Last Posted Date: 2012-09-12

Lead Sponsor: Chang Gung Memorial Hospital

Target Recruit Count: 60

Registration Number: NCT01683786

Locations: 🇨🇳
Pingtung Christian Hospital, Pingtung, Taiwan
🇨🇳
Chi Mei Medical Center - Liouying Branch, Tainan, Taiwan
🇨🇳
Chang Gung Medical Foundation, Kaohsiung Branch, Kaohsiung, Taiwan

and more 2 locations

Peripheral Plasma Micro-RNA and Proteomics Mapping in Depressive Patients, Treated With SSRI Medications

Terminated

Conditions: Depression

First Posted Date: 2012-09-10

Last Posted Date: 2015-06-19

Lead Sponsor: HaEmek Medical Center, Israel

Target Recruit Count: 17

Registration Number: NCT01681407

Locations: 🇮🇱
HaEmek Medical Center, Afula, Israel

Skeletal Muscle Apoptosis and Physical Performance; Oxidative RNA/DNA Damage and Repair in Aged Human Muscle

Completed

Conditions: Sarcopenia

First Posted Date: 2012-07-19

Last Posted Date: 2016-11-03

Lead Sponsor: University of Florida

Target Recruit Count: 63

Registration Number: NCT01644279

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia

Completed

Conditions: Leukemia

First Posted Date: 2012-06-22

Last Posted Date: 2016-05-17

Lead Sponsor: Children's Oncology Group

Target Recruit Count: 20

Registration Number: NCT01626183

DNA-based Influenza Vaccine in the Elderly

Phase 1

Completed

Conditions: RNA Virus Infections
Respiratory Tract Diseases
Virus Diseases
Influenza, Human
Orthomyxoviridae Infections
Respiratory Tract Infections

Interventions: Biological: FVH1 - a DNA-based influenza vaccine

First Posted Date: 2012-04-27

Last Posted Date: 2015-04-17

Lead Sponsor: University of Manitoba

Target Recruit Count: 50

Registration Number: NCT01587131

Locations: 🇨🇦
MS Building Health Sciences Centre, Winnipeg, Manitoba, Canada

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Terminated

Conditions: Lymphoma
Lung Cancer

Interventions: Genetic: DNA analysis
Genetic: RNA analysis
Genetic: gene expression analysis
Genetic: polymorphism analysis
Other: biologic sample preservation procedure
Other: flow cytometry
Other: medical chart review

First Posted Date: 2012-03-30

Last Posted Date: 2023-03-16

Lead Sponsor: AIDS Malignancy Consortium

Target Recruit Count: 114

Registration Number: NCT01567722

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
University of Pennsylvania - Abramson Cancer Center at Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
John H. Stroger Hospital of Cook County, Chicago, Illinois, United States

and more 11 locations

Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma

Phase 1

Withdrawn

Conditions: Lymphoma

Interventions: Drug: Lamivudine
Drug: Tenofovir disoproxil fumarate

First Posted Date: 2012-02-08

Last Posted Date: 2016-03-11

Lead Sponsor: University of Michigan Rogel Cancer Center

Registration Number: NCT01528865

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Prev
1
36
37
38
39
40
46
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy